Try the modernized ClinicalTrials.gov beta website. Learn more about the modernization effort.
Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Everolimus for Patients With Relapsed/Refractory Germ Cell Cancer (RADIT)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT01242631
Recruitment Status : Completed
First Posted : November 17, 2010
Last Update Posted : February 25, 2015
Sponsor:
Collaborator:
Novartis
Information provided by (Responsible Party):
Hannover Medical School